NEW YORK, Oct. 03, 2016 -- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, announces the commencement of an investigation into National Beverage Corp. (“National Beverage” or the “Company”) to determine whether the Officers and Directors of National Beverage have breached their fiduciary duties owed to National Beverage and its shareholders. National Beverage investors are encouraged to go to: http://www.scott-scott.com/cases/investigations/securities-fraud-litigation-2997-national-beverage-corp.html. You can also contact Joseph Halloran at (646) 582-0121, or email [email protected] for information.
National Beverage develops, produces, markets, and sells a portfolio of flavored beverage products primarily in North America. National Beverage offers beverages geared to the active and health-conscious consumers, including sparkling waters under the LaCroix, LaCroix Cúrate, LaCroix NiCola, and Shasta brand names.
On September 28, 2016, Glaucus Research reported, among other things, that former National Beverage CEO and Chairman admitted to "manipulating earnings” and instructing his son to “create fake invoices.” On this news, the price of Company shares declined over 8% on September 28, 2016.
WHAT YOU CAN DO
If you are a long-term National Beverage shareholder, you may have legal claims against the Company. If you have questions about your legal rights, please contact attorney Joseph Halloran at (800) 404-7770 or (646) 582-0121, or at [email protected].
ABOUT SCOTT+SCOTT, ATTORNEYS AT LAW, LLP
Scott+Scott has significant experience prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm has offices in New York, London, Connecticut, California, and Ohio. Please visit www.scott-scott.com for more information about the firm.
CONTACT Joseph V. Halloran Scott+Scott, Attorneys at Law, LLP (646) 582-0121 [email protected]


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Anta Sports Expands Global Footprint With Strategic Puma Stake
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



